What question did this study set out to answer?

This research aims to restore sensitivity to pomalidomide in multiple myeloma cells that have developed resistance.

April 5, 2026Cancer Research

Nanoparticle Mediated Restoration of Pomalidomide Sensitivity in Multiple Myeloma

View Full Paper

Ask AI

Bookmark

This research aims to restore sensitivity to pomalidomide in multiple myeloma cells that have developed resistance.
Designed lipid nanoparticles to deliver cereblon mRNA to resistant MM1.S cells.
Screened for peptides that bind to BCMA and CD38 proteins using phage display libraries.
Synthesized cyclic peptides for targeted delivery to malignant plasma cells.
Lipid nanoparticles effectively delivered cereblon mRNA to resistant cells.
Restoration of sensitivity to pomalidomide was significantly observed in treated cells.
Identified peptides with affinity for BCMA and CD38 are being tested for nanoparticle conjugation.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

This research demonstrates improved drug sensitivity in multiple myeloma using nanoparticle delivery of cereblon mRNA, indicating a potential therapy for resistant cases.

Cite This Study

Ogbede et al. (2026) studied this question.

synapsesocial.com/papers/69d1fceba79560c99a0a2a68 https://doi.org/10.1158/1538-7445.am2026-7122

View Full Paper

Ask AI

Bookmark

Implication

This research demonstrates improved drug sensitivity in multiple myeloma using nanoparticle delivery of cereblon mRNA, indicating a potential therapy for resistant cases.

Nanoparticle Mediated Restoration of Pomalidomide Sensitivity in Multiple Myeloma

Key Points

Discussion

Implication

Cite This Study

Nanoparticle Mediated Restoration of Pomalidomide Sensitivity in Multiple Myeloma

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider